4
Changes in Ownership
Atara Biotherapeutics, Inc. Filed Acc 0000905148-25-004140
Chief Accounting Officer sold 1,804 shares at an average $13.19 ($23,788)
From the SEC's structured data for this filing
Trades in this filing
Grant-Huerta Yanina · Chief Accounting Officer
Table I: Non-derivative
3 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2025-11-17 | Sale : show line 1 in the form | −1,645 | $13.19 | $21,691 | 33,613 | D |
| 2025-11-17 | Sale : show line 2 in the form | −85 | $13.19 | $1,121 | 33,528 | D |
| 2025-11-17 | Sale : show line 3 in the form | −74 | $13.19 | $976 | 33,454 | D |
| Open-market sales · 1,804 sh · avg $13.19 · $23,788 | ||||||
Loading xslF345X05/form4.xml…